Search

Your search keyword '"Kilgore, Mark R."' showing total 39 results
Start Over Author "Kilgore, Mark R."
39 results on '"Kilgore, Mark R."'

17. Multi-pilot implementation experiences of patient-centered pathology reports: Lessons learned for the advancement of patient-centered tools for cancer decision-making

Author

Austin, Elizabeth J., primary, Kilgore, Mark R., additional, Ko, Cynthia W., additional, Parker, Elizabeth U., additional, Alvarez, Rebeca, additional, Koch, Lisa K., additional, Donlan, Amelia W., additional, Lee, Janie M., additional, Flanagan, Meghan R., additional, DeStefano, Lauren M., additional, Javid, Sara H., additional, and Gore, John L., additional

Published
2022
Full Text
View/download PDF

19. CD200 Expression in Neuroendocrine Neoplasms

Author

Love, Jason E, Thompson, Kimberly, Kilgore, Mark R, Westerhoff, Maria, Murphy, Claire E, Papanicolau-Sengos, Antonios, McCormick, Kinsey A, Shankaran, Veena, Vandeven, Natalie, Miller, Faith, Blom, Astrid, Nghiem, Paul T, and Kussick, Steven J

Published
2017
Full Text
View/download PDF

22. Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues

Author

Kennedy, Jacob J, primary, Whiteaker, Jeffrey R, additional, Kennedy, Laura C, additional, Bosch, Dustin E, additional, Lerch, Melissa L, additional, Schoenherr, Regine M, additional, Zhao, Lei, additional, Lin, ChenWei, additional, Chowdhury, Shrabanti, additional, Kilgore, Mark R, additional, Allison, Kimberly H, additional, Wang, Pei, additional, Hoofnagle, Andrew N, additional, Baird, Geoffrey Stuart, additional, and Paulovich, Amanda G, additional

Published
2021
Full Text
View/download PDF

23. Improving the impact of clinical documentation through patient-driven co-design: experiences with cancer pathology reports

Author

Austin, Elizabeth J, Lee, Jenney R, Ko, Cynthia W, Kilgore, Mark R, Parker, Elizabeth U, Bergstedt, Brandelyn, Mitchell, Anita I, Javid, Sara H, and Gore, John L

Subjects
Patient Access to Records, Pathology, Clinical, patient care, BMJ health informatics, Documentation, Focus Groups, lcsh:Computer applications to medicine. Medical informatics, Neoplasms, Terminology as Topic, lcsh:R858-859.7, medical informatics, Electronic Health Records, Humans, Original Research
Abstract

Objective With the unprecedented rise of patient access to clinical documentation through electronic health records, there is a need for health systems to understand best practices for redesigning clinical documentation to support patient needs. This study used an experience-based co-design approach to inform the redesign of cancer pathology reports to improve their patient-centeredness and impact on patient engagement. Materials and methods Multiple methods for data collection and stakeholder engagement were used, including Delphi prioritisation with breast and colorectal cancer experts (n=78) and focus groups with patients with cancer (n=23) in the Seattle area. Iterative rounds of consensus generation and reflection were used to elicit themes and design recommendations for the development of patient-centred pathology reports on cancer care. Results Although each cancer type had nuanced elements to consider, common design requirements emerged around two key themes: (1) clinical documentation language should be framed in a way that informs and engages patients, and (2) clinical documentation format should be leveraged to enhance readability and information flow. Study activities illuminated detailed recommendations to improve the patient-centeredness of pathology reports based on patients’ and clinicians’ lived experience. Discussion The design requirements that emerged from this study provide a framework that can guide the rapid development of patient-centred pathology reports for all cancer types. Even further, health systems can replicate these methods to guide experience-based co-design of clinical documentation for contexts beyond cancer care. Conclusion This work offers practice-based learnings that can more effectively guide health systems in their clinical documentation redesign efforts.

Published
2020

30. Radiologic and Pathologic Correlation for Lactating Adenomas.

Author

Hoiwan Cheung, Parker, Elizabeth U., Kilgore, Mark R., and Scheel, John R.

Subjects
ADENOMA, LACTATION, BREAST ultrasound, PREGNANT women, TISSUE wounds
Abstract

Lactating adenomas are benign breast lesions that occur in pregnant, lactating, and postpartum women. These lesions have no associated malignant potential; their origin is disputed with no consensus on whether they represent hyperplastic or neoplastic processes. On ultrasound, lactating adenomas are classically described as solid, circumscribed, parallel masses with iso/ hypoechoic internal echotexture and posterior enhancement. Histologically, lactating adenomas appear as circumscribed nodules of tightly packed lobular acini with extensive lactational change during pregnancy or the postpartum period. Masses in pregnant and lactating women with probably benign imaging characteristics--oval, circumscribed, parallel, iso/hypoechoic--can be managed with short interval follow-up (BI-RADS 3) rather than biopsy. However, lactating adenomas can also demonstrate characteristics that overlap with pregnancy-associated breast cancer, such as margins that are not circumscribed, prompting biopsy to exclude pregnancy-associated carcinoma. Breast imaging radiologists must be aware of the variable appearances of lactating adenomas to appropriately manage pregnant and lactating women presenting with palpable lumps. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

31. Idiopathic Granulomatous Mastitis of the Breast: Radiologic--Pathologic Correlation.

Author

Kataria, Niketa, Parker, Elizabeth U., Kilgore, Mark R., and Scheel, John R.

Subjects
MASTITIS, IMMUNOGLOBULIN M, INFLAMMATION, BREAST cancer, MAMMOGRAMS
Abstract

Granulomatous inflammation is an uncommon inflammatory condition of the breast that includes both infectious (bacterial, fungal, parasitic) and noninfectious (autoimmune, sarcoidosis, idiopathic granulomatous mastitis [IGM], reaction to foreign materials) etiologies. IGM is the most common subset of granulomatous inflammation where no underlying etiology is established. Infectious causes of granulomatous inflammation should be excluded, as these have established treatments that can significantly improve patient outcomes. IGM should be considered in the differential when mastitis is refractory to antibiotics. Patients usually present with an erythematous, tender, palpable unilateral breast mass. The most common mammographic presentation is a focal or global asymmetry. The imaging appearance mimics breast cancer, therefore diagnosis usually requires tissue sampling with histopathologic analysis and cultures to exclude infection. When patients are diagnosed with IGM, this poses a clinical dilemma as there are a variety of treatment options available, including oral and intralesional steroids. The time course of the disease is often prolonged by multiple recurrences, and specific treatment remains an area of ongoing research. The purpose of this article is to review the range of clinical features, imaging manifestations, associated histopathology, and management of IGM. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

35. NDER

Author

Parker, Elizabeth U., primary, Reder, Nicholas P., additional, Glasser, Daniel, additional, Henriksen, Jonathan, additional, Kilgore, Mark R., additional, and Rendi, Mara H., additional

Published
2017
Full Text
View/download PDF

39. Error Reduction and Diagnostic Concordance in Breast Pathology

Author

Miller, Timothy Isaac, Flanagan, Meghan R., Lowry, Kathryn P., and Kilgore, Mark R.

Abstract

Errors in anatomic pathology can result in patients receiving inappropriate treatment and poor patient outcomes. Policies and procedures are necessary to decrease error and improve diagnostic concordance. Breast pathology may be more prone to diagnostic errors than other surgical pathology subspecialties due to inherit borderline diagnostic categories such as atypical ductal hyperplasia and low-grade ductal carcinoma in situ. Mandatory secondary review of internal and outside referral cases before treatment is effective in reducing diagnostic errors and improving concordance. Assessment of error through amendment/addendum tracking, implementing an incident reporting system, and multidisciplinary tumor boards can establish procedures to prevent future error.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results